Related Experiment Videos
Recurrent cervical carcinoma after radical hysterectomy
D M Larson1, L J Copeland, C A Stringer
1Department of Gynecology, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston.
Gynecologic Oncology
|July 1, 1988
Summary
Recurrent cervical carcinoma after surgery is common within two years, especially with pelvic node metastasis or adenocarcinoma. Pelvic recurrences can be successfully treated with irradiation.
Area of Science:
- Gynecologic Oncology
- Surgical Oncology
- Radiation Oncology
Background:
- Recurrence patterns after radical hysterectomy for cervical cancer are not well-defined.
- Understanding recurrence characteristics is crucial for improving patient outcomes.
Purpose of the Study:
- To characterize the patterns of disease recurrence following radical hysterectomy and pelvic lymphadenectomy for stage IB cervical carcinoma.
- To identify factors associated with recurrence and evaluate treatment outcomes.
Main Methods:
- Retrospective analysis of 249 patients with stage IB cervical carcinoma treated between 1962 and 1984.
- Detailed review of recurrence sites, timing, and treatment modalities.
Main Results:
- 11% of patients experienced recurrence, with 89% occurring within two years.
- Pelvic node metastasis (33%) and adenocarcinoma (22%) were associated with higher recurrence rates.
- 53% of patients with pelvic/vulvar recurrence treated with irradiation achieved long-term disease-free survival.
Conclusions:
- Early detection and vigilance for pelvic/vulvar recurrence are essential.
- Irradiation is an effective salvage treatment for localized pelvic recurrences after surgery.